A B S T R A C T The rates of catabolism of human yG-immunoglobulins of subclasses -yG1, yG2, yG8, and yG4 were studied by determining the rates of elimination from the circulation of pairs of 181I-and 125I-labeled -yG-myeloma proteins in 57 patients suffering from cancer other than multiple myeloma. On the average, yG1-, yG2-, and yG4-myeloma proteins were catabolized at a rate similar to that of normal yG-immunoglobulin, whereas yG3-myeloma proteins were catabolized more rapidly than normal yG-immunoglobulin. The average half-lives for the myeloma proteins were 12.3 days for normal -yG, 11.6 days for yG1, 12.4 days for -yG2, 8.2 days for yG3, and 11.3 days for yG4. However, significant differences in catabolic rates were observed when individual myeloma proteins of a single subclass were compared. These individual variations were present within all four heavy chain subclasses. The extent of differences ranged from 10 to 47%o. These findings indicate that the structure (s) related to the catabolism of yG-immunoglobulins are complex and differ from one immunoglobulin molecule to another.
A B S T R A C T The rates of catabolism of human yG-immunoglobulins of subclasses -yG1, yG2, yG8, and yG4 were studied by determining the rates of elimination from the circulation of pairs of 181I-and 125I-labeled -yG-myeloma proteins in 57 patients suffering from cancer other than multiple myeloma. On the average, yG1-, yG2-, and yG4-myeloma proteins were catabolized at a rate similar to that of normal yG-immunoglobulin, whereas yG3-myeloma proteins were catabolized more rapidly than normal yG-immunoglobulin. The average half-lives for the myeloma proteins were 12.3 days for normal -yG, 11.6 days for yG1, 12.4 days for -yG2, 8.2 days for yG3, and 11.3 days for yG4. However, significant differences in catabolic rates were observed when individual myeloma proteins of a single subclass were compared. These individual variations were present within all four heavy chain subclasses. The extent of differences ranged from 10 to 47%o. The catabolic rate of normal 'yG was in an intermediate range when compared with myeloma proteins of relatively long and short half-lives. The rate of catabolism of an individual myeloma protein did not correlate with its light chain type, Gm factor, carbohydrate content, or electrophoretic mobility.
INTRODUCTION
It has been shown by a number of investigators working with different species that immunoglobulins of different classes differ in their rates of in vivo catabolism. In man, -yG-immunoglobulins are relatively slowly catabolized with a half-life of about 20 days (1, 2), whereas yA-, yM-, and yD-immunoglobulins are more rapidly catabolized with average half-lives of 6 (3), 5 (4) , and 2.8 (5) days, respectively. Recently it has been demonstrated that human yG-immunoglobulins can be divided into four subclasses, yG1, yG2, yG3, and yG4, on the basis of antigenic differences in the heavy chain (6, 7).1 These four subclasses differ also in certain biological properties. Terry reported that yG1-, yG8-, and yG4-, but not 7G2-immunoglobulins induce a reverse passive cutaneous anaphylaxis in the guinea pig (8) . In addition, the subclasses differ in their abilities to fix complement (C'). yG1-and yG8-immunoglobulins fix C' very well, whereas yG2-immunoglobulins fix less C' and yG4-immunoglobulins probably do not fix C' at all (9, 10) . The present experiments were undertaken to study the catabolic rate of human yG-immunoglobulins of different heavy chain subclasses. It has previously been demonstrated that the submolecular structure responsible for the persistence in the circulation and the slow rate of catabolism of yG-immunoglobulins is also located in the heavy chain (11) (12) (13) . The catabolism of yG-myeloma proteins was studied since myeloma proteins are at the present time the only available source of relatively pure immunoglobulins of a particular heavy chain subclass. Because of the considerable variations in the rate of catabolism of -yG-globulin in man, pairs of 131I-and 1251-labeled myeloma proteins were injected to determine differences in the rate of catabolism in the same individual.
METHODS
Myelonia proteins. Eight -yG1-, five -yG2-, four yG3-, and three -yG4-myeloma proteins were isolated from the sera of patients with multiple myeloma either by Pevikon block electrophoresis (14) or by DEAE-cellulose chromatography (12) . The sera were stored at -20'C before the isolation of the myeloma proteins. Normal 7yG-immunoglobulin was isolated from the sera obtained from seven healthy donors by DEAE-cellulose chromatography using 0.01 M potassium phosphate buffer, pH 8.0 (12) . The heavy chain subclass of the isolated myeloma proteins was determined by double diffusion in agar as previously described (6), using either monkey or rabbit antisera specific for the heavy chain subclasses. The light chain type of the myeloma proteins was similarly determined using rabbit antisera specific for human K and X light chains (15) . The Gm factors of most of the myeloma proteins were kindly determined by Dr. S. Litwin and a few myeloma proteins according to the method described by Steinberg (16) 40 ,000 rpm for 60 min using a Titanium 50 rotor equipped with 2-ml tube adapters. Ultracentrifugation was performed to remove any aggregates that might be present. After ultracentrifugation, the upper 1.5 ml was carefully aspirated into disposable plastic syringes. The myeloma proteins injected into patients were sterilized by Millipore filtration using 0.45 mg filters. Determination of differences in half-lives. The patients were injected intravenously with a mixture containing two myeloma proteins, one labeled with 50-75 juc "~I and the other with 25-40 ,uc "2I. 10 min after injection, the first blood sample was drawn from the opposite arm used for the injection. The blood was collected in tubes containing dried EDTA. Subsequent blood samples were usually obtained 5, 8, 12, 15 , and 21 days after injection. Blood samples of the first six patients and of all patients injected with -yG3-myeloma proteins were obtained three times per week during the first 2 wk after injection. A single urine specimen was collected from all patients between 5 and 12 days after injection of the labeled myeloma proteins. Both plasma and urine samples were kept frozen at -20°C for a maximum of 2 wk before being analyzed. The TCA-precipitable radio-activity of 2 ml plasma was counted. The plasma sample obtained 10 min after injection was taken as the 100% value in order to calculate the per cent radioactivity remaining in the plasma after subsequent time intervals. The per cent 'I and 'I radioactivity in the plasma was plotted against time on semilogarithmic paper and the half-lives of both 'I-and 'I-labeled myeloma proteins were determined from the slope of the elimination curves following intra-and extravascular equilibration. The difference in the half-lives of two myeloma proteins in a patient was expressed as the per cent difference calculated by dividing the difference in half-lives by the longer half-life according to the formula: per cent difference = (tj long -ti short) /tj long X 100. A typical protocol is shown in Fig. 1 .
Chemical analysis. Hexoses were determined by the orcinol reaction as described by Svennerholm (21) reducing the sample and reagent volumes to 1 and 2 ml, respectively. An equimolar mixture of galactose and mannose was used as standard in concentrations of 0.058-0.233 ,umole/ml. Spectrophotometric readings were taken at 505 m,. The sialic acid was determined by the thiobarbituric acid assay described by Warren (22) . The protein preparations were first hydrolyzed in a final concentration of 0.1 x H2SO4 for 1 hr at 80°C. Protein nitrogen determinations were performed by a modification of the micro-Kjeldahl technique using an AutoAnalyzer (Technicon Co., Chauncey, N. Y.) (23) .
RESULTS
In all, 57 patients were injected either with different pairs of 131I-and 125I-labeled myeloma proteins or with normal -yG-immunoglobulin paired with myeloma proteins. Each patient received approximately 1 mg of each trace-labeled myeloma protein or normal yG-immunoglobulin. As can be seen in Table I , the average half-lives of yG1-, yG,-, and -yG4-myeloma proteins were similar with 11.6, 12.4, and 11.3 days, respectively, and did not differ significantly from the average half-life of T. C. The myeloma proteins were arbitrarily divided into three groups having either a relatively long, medium, or short half-life, in order to determine a possible correlation between half-life and known structural features of the myeloma proteins. As can be seen in Fig. 2 , no correlation existed between rate of catabolism and light chain type, Gm factor, hexose content, sialic acid content, and electrophoretic mobility of the 7G1-myeloma proteins studied. Similar data were obtained for the yG2-, yG8-, and yG4-myeloma proteins (Table V) .
The fraction of the myeloma proteins remaining in the intravascular compartment was determined in all patients by extrapolating the plasma elimination curves after equilibration between intraand extravascular spaces back to day 0 (Fig. 1) .
But for a single exception, the degree of intraand extravascular equilibration of any pair of myeloma proteins injected never differed by more than 3%. On the average 44% of the injected myeloma proteins or of the normal -yGimmunoglobulin remained in the intravascular compartment. The exception to this was a yG3-myeloma protein (Fel). This protein was unique, in that it contained bound lipoprotein and it is possible that some globulin-lipoprotein complexes might have been more rapidly eliminated from the two patients (T. B. and C. Ha., Table III ) obcirculation during the first few days after injection. tained 1 wk after injection of yG1-and -yG3-A single urine specimen obtained between 5 myeloma proteins contained about 0.2%o of the and 12 days after injection was analyzed from total injected radioactivity which was not precipievery patient for its content of both total and table with TCA. protein-bound radioactivity. No significant amount The yG-serum concentration was determined of protein-bound radioactivity was detected in the in every patient in order to study the relationship urine of any patient. A single stool specimen of between -yG-serum concentration and half-life of 
short half-life of a myeloma protein.
either the myeloma proteins or normal yGimmunoglobulin. The yG concentration remained constant during the 21 days of the study in 45 patients, whereas it either increased or decreased significantly in four patients. This change, however, had no apparent effect on the plasma elimination curve of the injected proteins. The 'yGserum concentrations varied in the 49 patients between 0.4 and 3.5 g/100 ml (Tables II, III, and  IV) . Comparison of the yG-concentration and half-life revealed a considerable variation and no good correlation between yG-concentration and half-lives.
DISCUSSION
The present data demonstrate that human yGmyeloma proteins are heterogeneous with respect to their catabolic rates. On the average, yG3- (24) .
It has previously been demonstrated that the submolecular structure related to the rate of catabolism of yG-immunoglobulin is located in the Fc fragment (11, 12) . The Fc fragment is eliminated from the circulation in a manner similar to L chain Gm Mol hexose Mol Nac T/2 the intact yG-molecule, whereas the Fab and F(ab')2 fragments are rapidly eliminated and catabolized (12) . Peptide maps of Fc fragments of myeloma proteins belonging to the same heavy chain subclass are, however, very similar except for allotypic differences (25, 26) , and do not suggest a heterogeneity in the-amino acid sequence that could be responsible for the heterogeneity in the catabolism of myeloma proteins of the same heavy chain subclass. When Fc fragments of yGmyeloma proteins that differed from one another in their catabolic rates were injected into mice and monkeys, no significant differences in the rate of elimination of the Fc fragments were observed.2 These findings suggest that a structure not present in the Fc fragment in some as yet undefined manner influences the rate of catabolism of -yGimmunoglobulins.
The heterogeneity in the catabolic rates of individual myeloma proteins may be partially explained by the theory proposed by Brambell for the mechanism of yG-catabolism (27) . This theory assumes that yG-immunoglobulins are pinocytosed at a constant rate and that a fraction of the pinocytosed yG attaches via a specific site to receptors which protect this fraction from proteolysis and subsequently return it to the circulation. The present data demonstrating different rates of catabolism of two yG-myeloma proteins in the same patient could be explained in at least two ways. (a) A heterogeneity of the site on the yG-molecule attaching to the protective receptor could allow certain molecules to compete better for the receptor and therefore they would be catabolized more slowly. (b) The site reacting with the receptor could be the same on each yG-molecule but differences in susceptibility to proteolysis from one species of molecules to another could result in different rates of catabolism, since an equilibrium between attached and unattached molecules would exist and the equilibrium would shift in favor of unattached molecules for those molecules being more rapidly digested.
The reason for the more rapid catabolism of yG3-myeloma proteins is not known. It probably does not reflect structural differences in the Fc fragment, since Fc fragments of yG3-myeloma proteins are catabolized at a rate similar to that of yG1-Fc fragments.2 Other structural differences between yG3 and those of the other subclasses might be responsible for the increased rate of catabolism of yG3-myeloma proteins. It has been shown in vitro that yG3-myeloma proteins are more susceptible to papain digestion than myeloma proteins of the other subclasses (28) . As mentioned above, an increased susceptibility to proteolysis might result in a more rapid rate of catabolism of -yG3-immunoglobulins. Although the present experiments offer no evidence for it, an alteration of the yG3-myeloma proteins could not definitely be excluded as a cause of the more rapid catabolism of -yG3-myeloma proteins.
A heterogeneity in the catabolic rate of mouse myeloma proteins similar to that observed in the present study for human myeloma proteins has been described by Fahey and Sell (29) . Although these authors did not study the catabolism of paired labeled myeloma proteins, the average halflives reported for individual mouse myeloma proteins suggest a catabolic heterogeneity within a given heavy chain subclass. In mice, y2b-myeloma proteins which share certain biological and chemical features with human yG3-myeloma proteins 3 were, as were human yG3-myeloma proteins, catabolized more rapidly than the other myeloma proteins.
The average half-lives of normal yG-immunoglobulin in the present study were shorter than those reported by other investigators for normal yG-immunoglobulin (1, 2). The explanation of this difference might lie in different catabolic rates of healthy individuals and chronically ill cancer patients and in technical differences. The longer half-lives have usually been obtained by measuring the retention of radioactivity in the body (1, 2) . The serum concentration of most of the injected patients was either within normal limits or slightly decreased. No good correlation between the yG-serum concentration and the half-lives of both normal and myeloma yG-immunoglobulins could be demonstrated. These findings are in agreement with those of Solomon, Waldmann, and 'Fahey, who also observed a considerable variation in healthy subjects whose yG-concen- 3 Grey, H. M. Unpublished observations. tration was within normal limits, and only in patients with extremely high or low yG-serum concentrations could a definite correlation between yG-serum concentration and rate of yG-catabolism be demonstrated (2) .
